IRIS
PONTREMOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.916
AS - Asia 3.169
NA - Nord America 2.764
Continente sconosciuto - Info sul continente non disponibili 611
SA - Sud America 281
AF - Africa 44
OC - Oceania 10
Totale 34.795
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.365
US - Stati Uniti d'America 2.585
SG - Singapore 1.296
CN - Cina 782
VN - Vietnam 398
BD - Bangladesh 393
FR - Francia 243
BR - Brasile 169
HK - Hong Kong 112
FI - Finlandia 78
AR - Argentina 57
CA - Canada 57
DE - Germania 54
MX - Messico 37
GB - Regno Unito 36
CH - Svizzera 34
JP - Giappone 33
IN - India 25
IQ - Iraq 25
ID - Indonesia 17
JM - Giamaica 17
NL - Olanda 17
CO - Colombia 15
ES - Italia 13
RU - Federazione Russa 13
PH - Filippine 12
PK - Pakistan 12
VE - Venezuela 12
CR - Costa Rica 11
EC - Ecuador 11
IE - Irlanda 10
NI - Nicaragua 10
UA - Ucraina 10
HN - Honduras 9
ZA - Sudafrica 9
AU - Australia 8
PL - Polonia 8
SA - Arabia Saudita 8
PR - Porto Rico 7
PY - Paraguay 7
DZ - Algeria 6
GT - Guatemala 6
TH - Thailandia 6
UZ - Uzbekistan 6
BB - Barbados 5
CL - Cile 5
MA - Marocco 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AT - Austria 4
JO - Giordania 4
KE - Kenya 4
MY - Malesia 4
PE - Perù 4
RO - Romania 4
SN - Senegal 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
KR - Corea 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
GA - Gabon 2
IR - Iran 2
KY - Cayman, isole 2
KZ - Kazakistan 2
LT - Lituania 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
SI - Slovenia 2
TR - Turchia 2
AD - Andorra 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MF - Saint Martin 1
MR - Mauritania 1
NG - Nigeria 1
Totale 34.177
Salva come PNG Salva come JPEG
Città #
Genova 16.085
Genoa 6.820
Rapallo 2.117
Vado Ligure 1.761
San Jose 649
Singapore 637
Ashburn 250
Lauterbourg 227
New York 170
Ho Chi Minh City 122
Beijing 118
Council Bluffs 118
Milan 108
Hong Kong 105
Hanoi 93
Santa Clara 82
Helsinki 74
Los Angeles 62
Rome 47
Bordighera 41
Frankfurt am Main 37
Buffalo 34
Naples 33
Zurich 32
Tokyo 29
Boardman 28
Chicago 24
Dallas 23
Phoenix 23
Mexico City 22
Tianjin 20
Orem 19
Turin 19
Brooklyn 18
Florence 18
São Paulo 18
Charlotte 15
Las Vegas 15
Philadelphia 14
St Louis 14
Bari 13
Bologna 13
City of London 13
Da Nang 13
The Dalles 13
Amsterdam 12
Atlanta 12
Kingston 12
Palermo 12
San Antonio 12
Toronto 12
Managua 10
Tampa 10
The Bronx 10
Cincinnati 9
Dublin 9
Jacksonville 9
Baghdad 8
Biên Hòa 8
East Brunswick 8
Haiphong 8
Miami 8
Nuremberg 8
San Francisco 8
Shanghai 8
Brescia 7
Hải Dương 7
Memphis 7
North Charleston 7
Pescara 7
San José 7
Washington 7
Boston 6
Cardiff 6
Columbus 6
Guangzhou 6
Houston 6
Madrid 6
Montreal 6
Parma 6
Seattle 6
Baltimore 5
Birmingham 5
Bridgetown 5
Buenos Aires 5
Can Tho 5
Caracas 5
Dayton 5
Des Moines 5
El Paso 5
Fort Worth 5
Indpls 5
Kyiv 5
Lexington 5
Long Beach 5
North Bergen 5
Padua 5
Pasadena 5
Portland 5
Rio de Janeiro 5
Totale 30.597
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 272
Left ventricular dilatation and subclinical renal damage in primary hypertension 265
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 220
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 219
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease 214
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 214
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 213
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 206
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 205
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 203
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 202
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 202
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 192
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 191
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 191
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 188
C-reactive protein and target organ damage in untreated patients with primary hypertension. 186
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 186
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 184
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH) 183
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 182
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 181
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 181
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals 180
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 180
Cardiovascular and renal effects of hyperuricaemia and gout. 179
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 179
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 177
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 177
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 177
Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes 175
Renal and cardiac abnormalities in primary hypertension 174
Blood pressure variability and multiple organ damage in primary hypertension 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 171
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 171
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 170
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 170
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 170
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 168
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 168
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 167
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 165
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 165
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 164
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 164
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 163
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 162
Microalbuminuria in primary hypertension: a guide to optimal patient management? 162
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 160
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 160
Amino acid imbalance in patients with chronic renal failure. 159
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 159
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 158
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 158
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 158
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 158
Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis 158
Creatinine clearance and early signs of target organ damage in primary hypertension 157
Use of nifedipine in the treatment of hypertension. 156
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 156
Sub-clinical organ damage in hypertension and obesity 156
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 155
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 154
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 154
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 154
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 153
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 152
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 151
Albuminuria: The kidney message on cardiovascular health 151
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 151
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 151
Hyperuricemia and renal risk 151
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 151
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 150
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 150
Mild renal dysfunction and renal vascular resistance in primary hypertension 150
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 149
Hypernatremia associated with severe rhabdomyolysis. 149
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 149
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 148
Renal ammoniagenesis in man with chronic potassium depletion. 148
Highlights from International Congress 148
Serum uric acid and risk of CKD in type 2 diabetes 148
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 148
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 147
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 146
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 146
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 145
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 145
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 143
Overall health assessment: a renal perspective. 143
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 143
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
Totale 17.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.345
article - articoli 111.270
book - libri 0
conference - conferenze 0
curatela - curatele 633
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 442
Totale 224.690
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.596 263 155 24 272 382 467 47 209 444 62 212 59
2023/20241.396 71 198 36 145 133 266 72 83 82 14 93 203
2024/20254.503 100 343 148 297 598 453 428 702 228 227 459 520
2025/20268.879 888 353 629 720 1.081 815 1.288 346 496 856 629 778
2026/2027863 863 0 0 0 0 0 0 0 0 0 0 0
Totale 34.795